公开(公告)号：US20070093373A1

公开(公告)日：2007-04-26

申请号：US11257968

申请日：2005-10-24

申请人： Nicholas Borrelli ,  George Hares ,  David McEnroe ,  Joseph Schroeder

发明人： Nicholas Borrelli ,  George Hares ,  David McEnroe ,  Joseph Schroeder

IPC分类号： C03C10/00 ,  C03C1/00

CPC分类号： G02B5/3025 ,  C03B23/047 ,  C03C3/064 ,  C03C4/08 ,  C03C14/006 ,  C03C2214/08

摘要： The invention is directed to a silver-containing polarizing boroaluminosilicate glass composition that has been doped with a noble metal selected from the group consisting of Pt, Pd, Os, Ir, Rh and Ru, including mixtures thereof,to nucleate and precipitate silver ions to silver metal without the need for a reducing atmosphere step. The invention is further directed to a method for making the glass composition of the invention. Using the composition and method of the invention, one can prepare a glass having a selected null transmission range.

摘要翻译： 本发明涉及掺杂有选自Pt，Pd，Os，Ir，Rh和Ru（包括它们的混合物）的贵金属的含银极化硼铝硅酸盐玻璃组合物，以使银离子成核并沉淀 银金属不需要还原气氛的步骤。 本发明还涉及制备本发明的玻璃组合物的方法。 使用本发明的组合物和方法，可以制备具有选定的无效透射范围的玻璃。

公开(公告)号：US20070093374A1

公开(公告)日：2007-04-26

申请号：US11584065

申请日：2006-10-20

申请人： Nicholas Borrelli ,  George Hares ,  Sasha Marjanovic ,  David McEnroe ,  Katherine Rossington ,  Joseph Schroeder

发明人： Nicholas Borrelli ,  George Hares ,  Sasha Marjanovic ,  David McEnroe ,  Katherine Rossington ,  Joseph Schroeder

IPC分类号： C03C10/00 ,  C03C1/00

CPC分类号： G02B5/3025 ,  C03B23/047 ,  C03C3/064 ,  C03C4/08 ,  C03C14/006 ,  C03C2214/08

摘要： The invention is directed to a silver-containing polarizing boroaluminosilicate glass composition that has been doped with a noble metal selected from the group consisting of Pt, Pd, Os, Ir, Rh and Ru, including mixtures thereof, to nucleate and precipitate silver ions to silver metal without the need for a reducing atmosphere step. The invention is further directed to a method for making the glass composition of the invention. Using the composition and method of the invention, one can prepare a glass having a selected null transmission range.

摘要翻译： 本发明涉及掺杂有选自Pt，Pd，Os，Ir，Rh和Ru（包括它们的混合物）的贵金属的含银极化性硼硅铝酸盐玻璃组合物，以使银离子成核并沉淀到 银金属不需要还原气氛的步骤。 本发明还涉及制备本发明的玻璃组合物的方法。 使用本发明的组合物和方法，可以制备具有选定的无效透射范围的玻璃。

公开(公告)号：US20070141350A1

公开(公告)日：2007-06-21

申请号：US11314874

申请日：2005-12-20

申请人： Nicholas Borrelli ,  David McEnroe ,  David McEnroe ,  Joseph Schroeder

发明人： Nicholas Borrelli ,  David McEnroe ,  David McEnroe ,  Joseph Schroeder

IPC分类号： B32B17/00 ,  C03C10/00 ,  C03B23/00

CPC分类号： C03B32/00 ,  C03C3/064 ,  C03C3/091 ,  C03C14/006 ,  C03C21/007 ,  C03C23/007 ,  C03C2214/08 ,  C03C2214/16 ,  Y10T428/315

摘要： The invention is directed to a method for preparing visible light optical polarizers using a non-halide silver salt and any glass composition that the non-halide silver salts is soluble, provided that the glass composition, including the silver salt, was a halide content that is, on a molar basis, 10% or less than the silver content, on a molar basis, of the glass composition. The silver containing glass is hydrogen reduced prior to stretching to form an optical polarizer. The invention enables one to form a visible light polarizer having a polarizing layer thickness in the range 10-40 μm in which the silver particles have a surround index sufficiently removed from the blue polarizer region to allow good contrast.

摘要翻译： 本发明涉及一种使用非卤化物银盐制备可见光光学偏振器的方法和任何非卤化物银盐可溶的玻璃组合物，只要包括银盐的玻璃组合物为卤化物含量， 以摩尔计，为玻璃组合物的基于摩尔的银含量的10％或更少。 含银玻璃在拉伸之前是氢还原以形成光学偏振片。 本发明使得能够形成具有10-40μm范围内的偏振层厚度的可见光偏振器，其中银颗粒具有从蓝色偏振片区域充分去除的环绕指数以允许良好的对比度。

公开(公告)号：US20050277540A1

公开(公告)日：2005-12-15

申请号：US10857070

申请日：2004-05-28

申请人： Nicholas Borrelli ,  George Hares ,  Mark Powley ,  Joseph Schroeder

发明人： Nicholas Borrelli ,  George Hares ,  Mark Powley ,  Joseph Schroeder

IPC分类号： C03C3/00 ,  C03C3/118 ,  C03C4/00 ,  C03C10/02 ,  C03C14/00 ,  G02B5/30

CPC分类号： G02B5/3083 ,  C03C3/118 ,  C03C4/00 ,  C03C14/006 ,  G02B5/3008

摘要： A birefringent glass composed of a phase-separated glass is provided. The phase-separated glass includes a borosilicate glass in which fluorine and a constituent that tends to crystallize into a high refractive index phase as a consequence of phase separation are included. In one embodiment, the constituent comprises TiO2.

摘要翻译： 提供由相分离玻璃构成的双折射玻璃。 相分离玻璃包括其中由于相分离而趋向于结晶成高折射率相的氟和组分的硼硅酸盐玻璃。 在一个实施方案中，组分包含TiO 2。

公开(公告)号：US09814874B2

公开(公告)日：2017-11-14

申请号：US12946266

申请日：2010-11-15

申请人： Timothy R. Jackson ,  Joseph Schroeder

发明人： Timothy R. Jackson ,  Joseph Schroeder

IPC分类号： A61N1/00 ,  A61N1/05

CPC分类号： A61N1/056 ,  A61N2001/0585

摘要： Lead electrodes having an asymmetrically distributed current density and methods for imparting current density directionality in lead electrodes are described. An implantable medical lead includes a lead body having a proximal section that connects to another implantable device and a distal section having a pre-biased shape configured to secure the lead to an inner wall of a body vessel. An electrode coupled to the distal section of the lead body includes a conductor mass having an asymmetrically distributed current density that imparts a directionality to one or more active portions of the electrode.

公开(公告)号：US20110160821A1

公开(公告)日：2011-06-30

申请号：US12946214

申请日：2010-11-15

申请人： Timothy R. Jackson ,  Joseph Schroeder

发明人： Timothy R. Jackson ,  Joseph Schroeder

IPC分类号： A61N1/05 ,  H01R43/20

CPC分类号： A61N1/056 ,  A61N2001/0585 ,  Y10T29/49208

摘要： An implantable medical lead having a modified electrode surface for imparting current density directionality within an electrode is disclosed. An implantable medical lead includes a lead body having a proximal section and a distal section having a pre-biased shape configured to secure the lead to an inner wall of a blood vessel. An electrode coupled to the distal section of the lead body includes a number of surface features on an inactive portion of the electrode that impart a current density directionality towards an active portion of the electrode that contacts the inner wall of the vessel. Methods for imparting current density directionality within an implantable lead electrode are also disclosed.

摘要翻译： 公开了一种植入式医用引线，其具有用于在电极内施加电流密度方向性的改性电极表面。 可植入医疗引线包括具有近端部分的引线主体和具有被配置为将引线固定到血管内壁的预偏置形状的远端部分。 耦合到引线主体的远端部分的电极包括在电极的非活性部分上的许多表面特征，其向接触容器的内壁的电极的有源部分赋予电流密度方向性。 还公开了在可植入引线电极内赋予电流密度方向性的方法。

公开(公告)号：US20070079755A1

公开(公告)日：2007-04-12

申请号：US10596106

申请日：2005-01-28

申请人： Gregory Strack ,  Jeffrey Perkins ,  Cynthia Skelton-Becker ,  Stephen Nemethy ,  Herman Turner ,  Kenneth Kreeger ,  Joseph Schroeder

发明人： Gregory Strack ,  Jeffrey Perkins ,  Cynthia Skelton-Becker ,  Stephen Nemethy ,  Herman Turner ,  Kenneth Kreeger ,  Joseph Schroeder

IPC分类号： B05B15/12

CPC分类号： B05B7/1454 ,  B05B7/1404 ,  B05B12/00 ,  B05B12/122 ,  B05B14/48

摘要： Material application system provided with a wireless identification technology for parts being processed and for components of the material application system. An exemplary technology is RFID. The RFID device can be used for many different functions including part identification, repair and maintenance programs, and inventory control.

摘要翻译： 材料应用系统为被处理的零件和材料应用系统的组件提供无线识别技术。 一种示例性技术是RFID。 RFID设备可用于许多不同的功能，包括部件识别，维修和维护程序以及库存控制。

公开(公告)号：US20070060571A1

公开(公告)日：2007-03-15

申请号：US11599519

申请日：2006-11-15

申请人： Ramani Bandarage ,  Upul Bandarage ,  Xinqin Fang ,  David Garvey ,  L. Letts ,  Joseph Schroeder ,  Sang Tam

发明人： Ramani Bandarage ,  Upul Bandarage ,  Xinqin Fang ,  David Garvey ,  L. Letts ,  Joseph Schroeder ,  Sang Tam

IPC分类号： A61K31/55 ,  A61K31/541 ,  A61K31/5377 ,  A61K31/496 ,  A61K31/454 ,  C07D417/02 ,  C07D413/02 ,  C07D403/02

CPC分类号： C07D207/333 ,  C07C317/46 ,  C07C381/00 ,  C07D209/12 ,  C07D209/18 ,  C07D231/12 ,  C07D231/14 ,  C07D233/64 ,  C07D237/14 ,  C07D261/08 ,  C07D263/20 ,  C07D307/58 ,  C07D311/12 ,  C07D413/12 ,  C07D471/04

摘要： The present invention describes novel nitrosated and/or nitrosylated cyclooxygenase 2 (COX-2) inhibitors and novel compositions comprising at least one nitrosated and/or nitrosylated cyclooxygenase 2 (COX-2) inhibitor, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or optionally, at least one therapeutic agent. The present invention also provides novel compositions comprising at least one parent COX-2 inhibitor and at least one nitric oxide donor, and, optionally, at least one therapeutic agent. The present invention also provides kits and methods for treating inflammation, pain and fever; for treating and/or improving the gastrointestinal properties of COX-2 inhibitors; for facilitating wound healing; for treating and/or preventing renal toxicity; and for treating and/or preventing other disorders resulting from elevated levels of cyclooxygenase-2.

摘要翻译： 本发明描述了新的亚硝化和/或亚硝基化的环氧合酶2（COX-2）抑制剂和包含至少一种亚硝化和/或亚硝基化的环氧合酶2（COX-2）抑制剂的新组合物，和任选的至少一种可以提供， 转移或释放一氧化氮，刺激一氧化氮的内源性合成，提高内皮衍生的松弛因子的内源水平，或者是一氧化氮合酶的底物和/或任选的至少一种治疗剂。 本发明还提供了包含至少一种母体COX-2抑制剂和至少一种一氧化氮供体以及任选的至少一种治疗剂的新型组合物。 本发明还提供用于治疗炎症，疼痛和发烧的试剂盒和方法; 用于治疗和/或改善COX-2抑制剂的胃肠性质; 促进伤口愈合; 用于治疗和/或预防肾毒性; 并且用于治疗和/或预防由环氧合酶-2水平升高引起的其它疾病。

公开(公告)号：US20070007894A1

公开(公告)日：2007-01-11

申请号：US11521888

申请日：2006-09-15

申请人： Bruce Aitken ,  Joel Carberry ,  Steven DeMartino ,  Henry Hagy ,  Lisa Lamberson ,  Richard Miller ,  Robert Morena ,  Joseph Schroeder ,  Alexander Streltsov ,  Sujanto Widjaja

发明人： Bruce Aitken ,  Joel Carberry ,  Steven DeMartino ,  Henry Hagy ,  Lisa Lamberson ,  Richard Miller ,  Robert Morena ,  Joseph Schroeder ,  Alexander Streltsov ,  Sujanto Widjaja

IPC分类号： H05B33/04 ,  H05B33/10 ,  H01L51/50

CPC分类号： C03C27/06 ,  C03C3/072 ,  C03C3/17 ,  C03C3/19 ,  C03C3/21 ,  C03C8/24 ,  C03C8/245 ,  C03C27/005 ,  H01L51/5246

摘要： A hermetically sealed glass package and method for manufacturing the hermetically sealed glass package are described herein using an OLED display as an example. Basically, the hermetically sealed OLED display is manufactured by providing a first substrate plate and a second substrate plate and depositing a frit onto the second substrate plate. OLEDs are deposited on the first substrate plate. An irradiation source (e.g., laser, infrared light) is then used to heat the frit which melts and forms a hermetic seal that connects the first substrate plate to the second substrate plate and also protects the OLEDs. The frit is glass that was doped with at least one transition metal and possibly a CTE lowering filler such that when the irradiation source heats the frit, it softens and forms a bond. This enables the frit to melt and form the hermetic seal while avoiding thermal damage to the OLEDs.

摘要翻译： 这里使用OLED显示器作为示例来描述气密密封的玻璃封装和制造密封玻璃封装的方法。 基本上，通过提供第一基板和第二基板并将玻璃料沉积到第二基板上来制造密封的OLED显示器。 OLED沉积在第一基板上。 然后使用照射源（例如，激光，红外光）来加热玻璃料，其熔化并形成将第一衬底板连接到第二衬底板并且还保护OLED的气密密封。 玻璃料是掺杂有至少一种过渡金属和可能的CTE降低填料的玻璃，使得当照射源加热玻璃料时，其软化并形成结合。 这使得玻璃料熔化并形成气密密封，同时避免对OLED的热损伤。

公开(公告)号：US20050222243A1

公开(公告)日：2005-10-06

申请号：US11134358

申请日：2005-05-23

申请人： Richard Earl ,  Maiko Ezawa ,  Xinqin Fang ,  David Garvey ,  Ricky Gaston ,  Subhash Khanapure ,  L. Gordon Letts ,  Chia-En Lin ,  Ramani Ranatunga ,  Stewart Richardson ,  Joseph Schroeder ,  Cheri Stevenson ,  Shiow-Jyi Wey

发明人： Richard Earl ,  Maiko Ezawa ,  Xinqin Fang ,  David Garvey ,  Ricky Gaston ,  Subhash Khanapure ,  L. Gordon Letts ,  Chia-En Lin ,  Ramani Ranatunga ,  Stewart Richardson ,  Joseph Schroeder ,  Cheri Stevenson ,  Shiow-Jyi Wey

IPC分类号： C07D295/08 ,  A61K31/21 ,  A61K31/405 ,  A61K31/445 ,  A61K45/00 ,  A61P1/00 ,  A61P1/04 ,  A61P1/10 ,  A61P1/14 ,  A61P3/04 ,  A61P17/02 ,  A61P25/28 ,  A61P27/02 ,  A61P29/00 ,  A61P35/00 ,  A61P35/02 ,  A61P43/00 ,  C07C203/04 ,  C07C205/40 ,  C07C205/56 ,  C07C219/10 ,  C07C229/42 ,  C07C235/08 ,  C07C235/12 ,  C07C235/34 ,  C07C235/42 ,  C07C237/08 ,  C07C243/28 ,  C07C271/16 ,  C07C271/64 ,  C07C291/02 ,  C07C311/17 ,  C07C317/18 ,  C07C317/32 ,  C07C317/46 ,  C07C323/12 ,  C07C327/28 ,  C07D209/18 ,  C07D209/28 ,  C07D211/22 ,  C07D211/56 ,  C07D493/04 ,  C07F9/40 ,  C07D209/20

CPC分类号： C07D493/04 ,  C07C291/02 ,  C07C311/17 ,  C07C317/18 ,  C07C323/12 ,  C07C327/28 ,  C07D209/18 ,  C07D211/22 ,  C07D211/56

摘要： The invention describes novel nitrosated nonsteroidal antiinflammatory drugs (NSAIDs) and pharmaceutically acceptable salts thereof, and novel compositions comprising at least one nitrosated NSAID, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or at least one therapeutic agent. The invention also provides novel compositions comprising at least one nitrosated NSAID, and at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one therapeutic agent. The invention also provides novel kits comprising at least one nitrosated NSAID, and, optionally, at least one nitric oxide donor and/or at least one therapeutic agent. The invention also provides methods for treating inflammation, pain and fever; for treating gastrointestinal disorders; for facilitating wound healing; for treating and/or preventing gastrointestinal, renal and/or respiratory toxicities resulting from the use of nonsteroidal antiinflammatory compounds; for treating inflammatory disease states and/or disorders; and for treating and/or preventing ophthalmic diseases and/or disorders.

摘要翻译： 本发明描述了新型亚硝化非甾体抗炎药（NSAID）及其药学上可接受的盐，以及包含至少一种亚硝化NSAID的新组合物，以及任选地至少一种捐赠，转移或释放一氧化氮的化合物，刺激一氧化氮的内源性合成 升高内源性内源性松弛因子水平，或是一氧化氮合酶的底物和/或至少一种治疗剂。 本发明还提供了包含至少一种亚硝化NSAID和至少一种捐赠，转移或释放一氧化氮的化合物的新型组合物，提高内源性内皮衍生的舒张因子水平，刺激一氧化氮的内源性合成，或是一氧化氮的底物 合酶和/或至少一种治疗剂。 本发明还提供了包含至少一种亚硝化NSAID和任选的至少一种一氧化氮供体和/或至少一种治疗剂的新型试剂盒。 本发明还提供了治疗炎症，疼痛和发烧的方法; 用于治疗胃肠道疾病; 促进伤口愈合; 用于治疗和/或预防由使用非甾体抗炎化合物引起的胃肠道，肾脏和/或呼吸道毒性物质; 用于治疗炎性疾病状态和/或病症; 并用于治疗和/或预防眼科疾病和/或病症。